158 related articles for article (PubMed ID: 15536604)
1. Effect of pioglitazone on the early stage of type 2 diabetic nephropathy in KK/Ta mice.
Tanimoto M; Fan Q; Gohda T; Shike T; Makita Y; Tomino Y
Metabolism; 2004 Nov; 53(11):1473-9. PubMed ID: 15536604
[TBL] [Abstract][Full Text] [Related]
2. Increased expression of endothelial cell nitric oxide synthase (ecNOS) in afferent and glomerular endothelial cells is involved in glomerular hyperfiltration of diabetic nephropathy.
Sugimoto H; Shikata K; Matsuda M; Kushiro M; Hayashi Y; Hiragushi K; Wada J; Makino H
Diabetologia; 1998 Dec; 41(12):1426-34. PubMed ID: 9867209
[TBL] [Abstract][Full Text] [Related]
3. Glomerular changes in the KK-Ay/Ta mouse: a possible model for human type 2 diabetic nephropathy.
Ito T; Tanimoto M; Yamada K; Kaneko S; Matsumoto M; Obayashi K; Hagiwara S; Murakoshi M; Aoki T; Wakabayashi M; Gohda T; Funabiki K; Maeda K; Horikoshi S; Tomino Y
Nephrology (Carlton); 2006 Feb; 11(1):29-35. PubMed ID: 16509929
[TBL] [Abstract][Full Text] [Related]
4. Effects of candesartan, an angiotensin II type 1 receptor blocker, on diabetic nephropathy in KK/Ta mice.
Liao J; Kobayashi M; Kanamuru Y; Nakamura S; Makita Y; Funabiki K; Horikoshi S; Tomino Y
J Nephrol; 2003; 16(6):841-9. PubMed ID: 14736011
[TBL] [Abstract][Full Text] [Related]
5. Beraprost sodium, prostacyclin analogue, attenuates glomerular hyperfiltration and glomerular macrophage infiltration by modulating ecNOS expression in diabetic rats.
Yamashita T; Shikata K; Matsuda M; Okada S; Ogawa D; Sugimoto H; Wada J; Makino H
Diabetes Res Clin Pract; 2002 Sep; 57(3):149-61. PubMed ID: 12126764
[TBL] [Abstract][Full Text] [Related]
6. Candesartan reduced advanced glycation end-products accumulation and diminished nitro-oxidative stress in type 2 diabetic KK/Ta mice.
Fan Q; Liao J; Kobayashi M; Yamashita M; Gu L; Gohda T; Suzuki Y; Wang LN; Horikoshi S; Tomino Y
Nephrol Dial Transplant; 2004 Dec; 19(12):3012-20. PubMed ID: 15574998
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide system is involved in glomerular hyperfiltration in Japanese normo- and micro-albuminuric patients with type 2 diabetes.
Hiragushi K; Sugimoto H; Shikata K; Yamashita T; Miyatake N; Shikata Y; Wada J; Kumagai I; Fukushima M; Makino H
Diabetes Res Clin Pract; 2001 Sep; 53(3):149-59. PubMed ID: 11483230
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide synthase isoforms and glomerular hyperfiltration in early diabetic nephropathy.
Veelken R; Hilgers KF; Hartner A; Haas A; Böhmer KP; Sterzel RB
J Am Soc Nephrol; 2000 Jan; 11(1):71-79. PubMed ID: 10616842
[TBL] [Abstract][Full Text] [Related]
9. Thiazolidinedione derivatives ameliorate albuminuria in streptozotocin-induced diabetic spontaneous hypertensive rat.
Yamashita H; Nagai Y; Takamura T; Nohara E; Kobayashi K
Metabolism; 2002 Apr; 51(4):403-8. PubMed ID: 11912544
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes.
Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A
Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434
[TBL] [Abstract][Full Text] [Related]
11. Relations between ACE gene and ecNOS gene polymorphisms and resistive index in type 2 diabetic patients with nephropathy.
Taniwaki H; Ishimura E; Matsumoto N; Emoto M; Inaba M; Nishizawa Y
Diabetes Care; 2001 Sep; 24(9):1653-60. PubMed ID: 11522715
[TBL] [Abstract][Full Text] [Related]
12. Tofogliflozin, a selective inhibitor of sodium-glucose cotransporter 2, suppresses renal damage in KKAy/Ta mice, obese and type 2 diabetic animals.
Ishibashi Y; Matsui T; Yamagishi SI
Diab Vasc Dis Res; 2016 Nov; 13(6):438-441. PubMed ID: 27407083
[TBL] [Abstract][Full Text] [Related]
13. Effect of pitavastatin on type 2 diabetes mellitus nephropathy in KK-Ay/Ta mice.
Matsumoto M; Tanimoto M; Gohda T; Aoki T; Murakoshi M; Yamada K; Yamazaki T; Kaneko S; Horikoshi S; Tomino Y
Metabolism; 2008 May; 57(5):691-7. PubMed ID: 18442635
[TBL] [Abstract][Full Text] [Related]
14. Effect of pyridoxamine (K-163), an inhibitor of advanced glycation end products, on type 2 diabetic nephropathy in KK-A(y)/Ta mice.
Tanimoto M; Gohda T; Kaneko S; Hagiwara S; Murakoshi M; Aoki T; Yamada K; Ito T; Matsumoto M; Horikoshi S; Tomino Y
Metabolism; 2007 Feb; 56(2):160-7. PubMed ID: 17224327
[TBL] [Abstract][Full Text] [Related]
15. Effects of vitamin D combined with pioglitazone hydrochloride on bone mineral density and bone metabolism in Type 2 diabetic nephropathy.
Wang LX; Wang N; Xu QL; Yan W; Dong L; Li BL
Biosci Rep; 2017 Apr; 37(2):. PubMed ID: 28153916
[TBL] [Abstract][Full Text] [Related]
16. Involvement of hyperglycemia in deposition of aggregated protein in glomeruli of diabetic mice.
Hirasawa Y; Matsui Y; Ohtsu S; Yamane K; Toyoshi T; Kyuki K; Sakai T; Feng Y; Nagamatsu T
Eur J Pharmacol; 2008 Dec; 601(1-3):129-35. PubMed ID: 18950619
[TBL] [Abstract][Full Text] [Related]
17. Dual therapy of vildagliptin and telmisartan on diabetic nephropathy in experimentally induced type 2 diabetes mellitus rats.
Sharma AK; Kanawat DS; Mishra A; Dhakad PK; Sharma P; Srivastava V; Joshi S; Joshi M; Raikwar SK; Kurmi MK; Srinivasan BP
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):410-8. PubMed ID: 23396552
[TBL] [Abstract][Full Text] [Related]
18. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
[TBL] [Abstract][Full Text] [Related]
19. Pioglitazone ameliorates glomerular NLRP3 inflammasome activation in apolipoprotein E knockout mice with diabetes mellitus.
Wang Y; Yu B; Wang L; Yang M; Xia Z; Wei W; Zhang F; Yuan X
PLoS One; 2017; 12(7):e0181248. PubMed ID: 28708885
[TBL] [Abstract][Full Text] [Related]
20. The role of adrenomedullin and receptors in glomerular hyperfiltration in streptozotocin-induced diabetic rats.
Hiragushi K; Wada J; Eguchi J; Matsuoka T; Yasuhara A; Hashimoto I; Yamashita T; Hida K; Nakamura Y; Shikata K; Minamino N; Kangawa K; Makino H
Kidney Int; 2004 Feb; 65(2):540-50. PubMed ID: 14717924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
